Carrier frequency of SMA in the general population is high at approximately 1 in 33–94 worldwide (2, 11, 13, 15, 16), and potentially with the most severe phenotype due to the high frequency of ≤ 2 copies of SMN2 among the carriers (15, 17–21). Here, SMN2 is linked to proximal spinal muscular atrophy.